| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/03/1997 | WO1997011700A1 Method for treating a tic disorder |
| 04/03/1997 | WO1997011699A1 1,2,4-benzotriazine oxides formulations |
| 04/03/1997 | WO1997011698A1 ALPHA 1b ADRENERGIC RECEPTOR ANTAGONISTS |
| 04/03/1997 | WO1997011696A1 Transdermal administration of ropinirole and analogs thereof |
| 04/03/1997 | WO1997011695A1 Substituted indolylpropyl-piperazine derivatives as 5-ht1dalpha agonists |
| 04/03/1997 | WO1997011694A1 Creatine for the protection of neural tissue |
| 04/03/1997 | WO1997011693A1 Guanidino protease inhibitors |
| 04/03/1997 | WO1997011692A2 Protein tyrosine kinase inhibitors for treating osteoarthritis |
| 04/03/1997 | WO1997011691A1 Treatment of human prostate cancer with spermine |
| 04/03/1997 | WO1997011690A2 Inhibitors of regulatory pathways |
| 04/03/1997 | WO1997011688A1 Use of a vinyl acetate/n-vinyl-2-pyrrolidone copolymer in a transdermal matrix system |
| 04/03/1997 | WO1997011684A1 Use of heparinases to decrease inflammatory responses |
| 04/03/1997 | WO1997011682A2 Emulsion and micellar formulations for the delivery of biologically active substances to cells |
| 04/03/1997 | WO1997011680A2 Hormone replacement therapy method and hormone dispenser |
| 04/03/1997 | WO1997011668A2 TUMOR NECROSIS FACTOR ALPHA (TNF-α) INHIBITING PHARMACEUTICALS |
| 04/03/1997 | WO1997011667A2 Therapeutic applications using horse serum |
| 04/03/1997 | WO1997011666A2 Use of 2-mercaptoethanolamine (2-mea) and related aminothiol compounds and copper(ii)-3,5 di-isopropyl salicylates and related compounds in the prevention and treatment of various diseases |
| 04/03/1997 | WO1997011655A1 Implantable controlled release device to deliver drugs directly to an internal portion of the body |
| 04/03/1997 | WO1997011653A1 Photochemistry for the preparation of biologic grafts-allografts and xenografts |
| 04/03/1997 | WO1997011611A1 Aliphatic amide feed supplement for ruminants |
| 04/03/1997 | WO1997011607A1 Method of inhibiting immune system destruction of transplanted viable cells |
| 04/03/1997 | WO1997011605A1 Stimulation of cell-mediated immune responses by targeted particulate genetic immunization |
| 04/03/1997 | WO1997011604A1 Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains |
| 04/03/1997 | WO1997011598A1 Method for treating hepatitis virus infection |
| 04/03/1997 | WO1997009317A3 Optically active phenyl pyrimidine derivative as analgesic agent |
| 04/03/1997 | WO1997005771A3 Lysosomal proteins produced in the milk of transgenic animals |
| 04/03/1997 | WO1996038473A3 Antimicrobial cationic peptides |
| 04/03/1997 | DE19536394A1 Feste Arzneiformen, erhältlich durch Extrusion einer Isomalt enthaltenden Polymer-Wirkstoff-Schmelze Solid dosage forms obtainable by extrusion of an isomalt-containing polymer-drug melt |
| 04/03/1997 | DE19535948A1 Antimicrobial cosmetic or dermatological compsn |
| 04/03/1997 | CA2502761A1 Implantable controlled release device to deliver drugs directly to an internal portion of the body |
| 04/03/1997 | CA2233445A1 2-mercaptoethanolamine, copper di-isopropyl salicylate, and related compounds |
| 04/03/1997 | CA2233344A1 Guanidino protease inhibitors |
| 04/03/1997 | CA2233343A1 Use of heparinases to decrease inflammatory responses |
| 04/03/1997 | CA2233334A1 Transdermal administration of ropinirole and analogs thereof |
| 04/03/1997 | CA2233297A1 Identification of sel-12 and uses thereof |
| 04/03/1997 | CA2233278A1 Stimulation of cell-mediated immune responses by targeted particulate genetic immunization |
| 04/03/1997 | CA2233204A1 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation |
| 04/03/1997 | CA2233168A1 Modified ether glyceroglycolipids |
| 04/03/1997 | CA2233167A1 Method for transferring genes to the heart using aav vectors |
| 04/03/1997 | CA2233138A1 Inhibitors of integrin receptors and their therapeutical uses |
| 04/03/1997 | CA2233060A1 Glycoprotein b of the rfhv/kshv subfamily of herpes viruses |
| 04/03/1997 | CA2233015A1 Therapeutic applications using horse serum |
| 04/03/1997 | CA2232950A1 Novel peptides useful in enhancement of fsh action |
| 04/03/1997 | CA2232821A1 Metal complexes as cysteine protease inhibitors |
| 04/03/1997 | CA2232815A1 Method of inhibiting immune system destruction of transplanted viable cells |
| 04/03/1997 | CA2232706A1 Chemokine inhibitor |
| 04/03/1997 | CA2232621A1 Hormone replacement therapy method and hormone dispenser |
| 04/03/1997 | CA2232559A1 Method for treating a tic disorder |
| 04/03/1997 | CA2232260A1 Substituted indolylpropyl-piperazine derivatives as 5-ht1dalpha agonists |
| 04/03/1997 | CA2232138A1 Alpha 1b adrenergic receptor antagonists |
| 04/03/1997 | CA2231764A1 Tumor necrosis factor alpha (tnf-.alpha.) inhibiting pharmaceuticals |
| 04/03/1997 | CA2231550A1 Compositions for treating inflammation containing certain prostaglandins and a selective cyclooxygenase-2 inhibitor |
| 04/03/1997 | CA2231434A1 Method of preventing androgenetic alopecia with 5-.alpha. reductase inhibitors |
| 04/03/1997 | CA2231064A1 Pharmaceutical composition useful for nucleic acid transfection, and use thereof |
| 04/03/1997 | CA2230940A1 Emulsion and micellar formulations for the delivery of biologically active substances to cells |
| 04/03/1997 | CA2230121A1 Product and process to regulate actin polymerization |
| 04/02/1997 | EP0765884A1 Anti-inflammatory compound |
| 04/02/1997 | EP0765879A1 13-Substituted milbemycin 5-oxime derivatives, their preparation and their use against insects and other pests |
| 04/02/1997 | EP0765878A1 Heterocyclic aryl-, alkyl- and cycloalkylacetic acid amides |
| 04/02/1997 | EP0765877A1 5,6,7,8-Tetrahyronaphto(2,3-b)furan- and indano(5,6-b)furan-amino-compounds, processes for their preparation and pharmaceutical compositions containing them |
| 04/02/1997 | EP0765873A1 Cyclic ureas and analogues useful as retroviral protease inhibitors |
| 04/02/1997 | EP0765871A1 Substituted Quinoline-2-carboxamides, their preparation and their use as prolyle-4-hydroxylase Inhibitors |
| 04/02/1997 | EP0765867A1 Substituted benzoyl guanidines, process for their preparation, their use as antiarrhythmics or diagnostic agent as well as pharmaceuticals containing them |
| 04/02/1997 | EP0765866A2 Preparation of optically active (S)-(-) and (R)-(+)- deoxyspergualin and novel intermediates thereof |
| 04/02/1997 | EP0765668A1 Extract of Iridaceas and composition containing it |
| 04/02/1997 | EP0765666A1 Inhibition of irregular binding of lens cells |
| 04/02/1997 | EP0765665A1 Use of dideoxy nucleoside analogues in the treatment of viral infections |
| 04/02/1997 | EP0765664A1 Stable aqueous suspension of mesalazine for topical use |
| 04/02/1997 | EP0765662A1 Hiv growth inhibitory composition |
| 04/02/1997 | EP0765661A2 Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of glumerulonephritis |
| 04/02/1997 | EP0765660A2 Microcapsules comprising 2-piperazinone-1-acetic acid compounds |
| 04/02/1997 | EP0765658A1 Use of salicylic acid derivatives for the treatment of striae |
| 04/02/1997 | EP0765357A1 Antiviral dendrimers |
| 04/02/1997 | EP0765336A1 Synthesis of conduritol epoxides and aziridines and methods of using such to synthesize higher disaccharides |
| 04/02/1997 | EP0765330A1 Lactam inhibitors of cholesterol esterase |
| 04/02/1997 | EP0765329A1 Rapamycin amidino carbamates and pharmaceutical compositions containing them |
| 04/02/1997 | EP0765328A1 Pirydyl imidazole derivatives and processes for the preparation thereof |
| 04/02/1997 | EP0765327A1 Pyrazolo and pyrrolopyridines |
| 04/02/1997 | EP0765326A1 Benzoylecgonine, ecgonine and ecgonidine derivatives |
| 04/02/1997 | EP0765325A1 Novel 1,1-bis(heteroazolyl)alkane derivatives and their use as neuroprotective agents |
| 04/02/1997 | EP0765323A1 4-(6-fluoro-1,2-benzisoxazolyl)-1-piperidinyl-propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis, schizophrenia and anxiety |
| 04/02/1997 | EP0765322A1 Indole derivatives as prodrugs of 5-ht 1?-like receptor agonists |
| 04/02/1997 | EP0765321A1 2-amino-3-aroyl-benzo beta thiophenes and method of making the same |
| 04/02/1997 | EP0765320A1 Benzimidazolone derivatives with central dopaminergic activity |
| 04/02/1997 | EP0765314A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators |
| 04/02/1997 | EP0765313A1 N,n'-bis(quinolin-4-yl)-diamine derivatives, their preparation and their use as antimalarials |
| 04/02/1997 | EP0765312A1 4-carbamoyloxy-piperidine-1-carboxylic acid esters: inhibitors of cholesterol absorption |
| 04/02/1997 | EP0765311A1 4-aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl)piperidines, tetrahydropyridines or piperazines |
| 04/02/1997 | EP0765308A1 Enzyme inhibitors |
| 04/02/1997 | EP0765305A1 Anti-inflammatory compounds |
| 04/02/1997 | EP0765162A1 A method for treating pain and brain perfusion abnormalities |
| 04/02/1997 | EP0765161A2 Synergistic antibiotic compositions containing a perphyrin and an antibiotic |
| 04/02/1997 | EP0765160A1 Dexanabinol derivatives and their use as neuroprotective pharmaceutical compositions |
| 04/02/1997 | EP0765151A1 Antibacterial oil-in-water emulsions |
| 04/02/1997 | EP0765126A1 Therapeutic food composition and method to diminish blood sugar fluctuations |
| 04/02/1997 | EP0741728A4 Improved process for synthesizing carbapenem intermediates |
| 04/02/1997 | EP0739335A4 Pyrrolidine-containing monomers and oligomers |
| 04/02/1997 | EP0736021A4 Polymorphs of losartan and the process for the preparation of form ii of losartan |
| 04/02/1997 | EP0680482B1 Process for the manufacture of a tricyclic compound |
| 04/02/1997 | EP0680323B1 Synergising association having an antagonist effect on nk1 and nk2 receptors |